Outcomes of Eyes Lost to Follow-Up in Patients with Central Retinal Vein Occlusion Who are Receiving Anti-Vascular Endothelial Growth Factor Treatment

References

• Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133–141; discussion 141–133.
   PubMedGoogle Scholar
• Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1243–1247. doi:10.1001/archopht.1996.01100140443012
   PubMed Web of Science ®Google Scholar
• Yeh S, Kim SJ, Ho AC, et al. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122:769–778. doi:10.1016/j.ophtha.2014.10.013
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2019;242:123–162. doi:10.1159/000502041
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a Phase III study. Ophthalmology. 2011;118:2041–2049. doi:10.1016/j.ophtha.2011.02.038
   PubMed Web of Science ®Google Scholar
• Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012;119:802–809. doi:10.1016/j.ophtha.2011.12.005
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Sophie R, Pearlman J, et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014;121:209–219. doi:10.1016/j.ophtha.2013.08.038
   PubMed Web of Science ®Google Scholar
• Gao X, Obeid A, Adam MK, et al. Loss to follow-up in patients with retinal vein occlusion undergoing intravitreal anti-VEGF Injections. Ophthalmic Surg Lasers Imaging Retina. 2019;50:159–166. doi:10.3928/23258160-20190301-05
   PubMed Web of Science ®Google Scholar
• Wubben TJ, Johnson MW; Anti VTISG. Anti-vascular endothelial growth factor therapy for diabetic retinopathy: consequences of inadvertent treatment interruptions. Am J Ophthalmol. 2019;204:13–18. doi:10.1016/j.ajo.2019.03.005
   PubMed Web of Science ®Google Scholar
• Khayat M, Williams M, Lois N. Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion. Surv Ophthalmol. 2018;63:816–850. doi:10.1016/j.survophthal.2018.04.005
   PubMed Web of Science ®Google Scholar
• Ogura Y, Roider J, Korobelnik JF, et al. Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the Phase 3 GALILEO study. Am J Ophthalmol. 2014;158:1032–1038. doi:10.1016/j.ajo.2014.07.027
   PubMed Web of Science ®Google Scholar
• Heier JS, Clark WL, Boyer DS, et al. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study. Ophthalmology. 2014;121:1414–1420 e1411. doi:10.1016/j.ophtha.2014.01.027
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhou H, Lin B, et al. Efficacy and safety of intravitreal conbercept injections in macular edema secondary to retinal vein occlusion. Retina. 2017;37:1723–1730. doi:10.1097/IAE.0000000000001404
   PubMed Web of Science ®Google Scholar
• Ehlken C, Helms M, Bohringer D, et al. Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients. Clin Ophthalmol. 2018;12:13–20. doi:10.2147/OPTH.S151611
   PubMed Web of Science ®Google Scholar
• McIntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1113–1123 e1115. doi:10.1016/j.ophtha.2010.01.060
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Freund KB, Peiretti E, et al. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina. 2007;27:426–431. doi:10.1097/IAE.0b013e31804a7af2
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez JM, Berrocal M. Rebound neovascularization during bevacizumab therapy. Retin Cases Brief Rep. 2010;4:216–219. doi:10.1097/ICB.0b013e3181af5596
   PubMedGoogle Scholar
• Yang KB, Feng H, Zhang H. Effects of the COVID-19 pandemic on anti-vascular endothelial growth factor treatment in China. Front Med (Lausanne). 2020;7:576275. doi:10.3389/fmed.2020.576275
   PubMed Web of Science ®Google Scholar
• A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology. 1995;102:1434–1444. doi:10.1016/S0161-6420(95)30848-2
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Hafiz G, Mir TA, et al. Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE Trial. Ophthalmology. 2015;122(7):1426–1437. doi:10.1016/j.ophtha.2015.04.006
   PubMed Web of Science ®Google Scholar
• Rehak M, Tilgner E, Franke A, et al. Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study). Graefes Arch Clin Exp Ophthalmol. 2014;252:745–752. doi:10.1007/s00417-013-2528-8
   PubMed Web of Science ®Google Scholar
• Nourinia R, Emamverdi M, Ramezani A, et al. Peripheral ischemic retinal photocoagulation in addition to intravitreal bevacizumab versus intravitreal bevacizumab alone for the treatment of macular edema secondary to central retinal vein occlusion: a Randomized Double-Masked Controlled Clinical Trial. Retina. 2019. doi:10.1097/IAE.0000000000002573
   Web of Science ®Google Scholar
• Maltsev DS, Kulikov AN, Burnasheva MA. [Selective panretinal laser photocoagulation in ischemic central retinal vein occlusion]. Vestn Oftalmol. 2020;136:147–154. (Russia). doi:10.17116/oftalma2020136062147
   PubMedGoogle Scholar